About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Cohance Lifesciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value
117.11
NSE Code
COHANCE
Dividend Yield %
0.00
Market Cap
175234.88
P/E
76.62
EPS
5.98
Face Value
1
BSE
NSE
23-Jun-2026
BSE
NSE
NSE F & O
23-Jun-2026
BSE
NSE
NSE F & O
Last Price
458.05
Net Change
51.8
% Change
12.75%
Prev.Close
406.25
Open
402.80
High
487.50
Low
402.80
Volume
1496455
Last Price
457.80
Net Change
52.55
% Change
12.97%
Prev.Close
405.25
Open
405.95
High
486.30
Low
405.95
Volume
26490915
Value
687235875
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
487.50
52-Week High
1121.15
52-Week Low
267.85
Value
12190351135.1
Best Buy
457.80
Best Sell
0.00
Best Quantity
12612
Sell Quantity
0
Today's Range
486.30
52-Week High
1121.15
52-Week Low
266.70
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
12612
Price
457.80
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 1
25-Sep-20
Book Closure
07-Aug-24
09-Aug-24
Dividend
100 %
12-Sep-22
Company News
19-06-2026
Cohance Lifesciences info...
19-06-2026
Cohance Lifesciences info...
18-06-2026
Cohance Lifesciences info...
29-04-2026
Clarification sought fro...
27-04-2026
Cohance Lifesciences info...
20-02-2026
Cohance Lifesciences info...
04-02-2026
Cohance Lifesciences info...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Scores
|
Policies of JFSL
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
|
Rights and obligation
|
SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
